How much funding has Novavax raised?

Novavax has raised $2.0B in total funding, most recently a Venture Round.

Who are Novavax's investors?

Novavax's investors include MidCap Financial, Operation Warp Speed (U.S. Government), Coalition for Epidemic Preparedness Innovations (CEPI), Bill & Melinda Gates Foundation.

Where is Novavax headquartered?

Novavax is headquartered in Gaithersburg, Maryland, United States.

What industry is Novavax in?

Novavax operates in Healthcare.

How many employees does Novavax have?

Novavax has 501-1000 employees.

Novavax

IPO

Powering What's Possible

Public · Gaithersburg, United States · Founded 1987 · $2.0B raised

Healthcare

Headquarters: Gaithersburg, Maryland
Employees: 501–1000
Founded: 1987
Business Model: B2B
Website: novavax.com

Total Funding: $2.0B
Last Round: $330.0M Venture RoundFeb 2026
Rounds: 5
Type: Public

About

Novavax is a global biotechnology company that discovers, develops, and commercializes vaccines for infectious diseases using its proprietary protein-based nanoparticle technology and Matrix-M adjuvant. Focused on maximizing R&D asset value through strategic partnerships, Novavax has developed vaccines targeting COVID-19, influenza, RSV, malaria, and other areas of unmet medical need. The company employs approximately 970 people and is headquartered in Gaithersburg, Maryland.

Summary

Novavax is a Healthcare company based in Gaithersburg, United States, founded in 1987. It has raised $2.0B in total across 5 rounds, most recently a $330.0M Venture Round round in Feb 2026. Investors include MidCap Financial, Operation Warp Speed (U.S. Government) and Coalition for Epidemic Preparedness Innovations (CEPI).

LinkedIn X (Twitter)